Prognostic Value of Baseline Total Metabolic Tumor Volume Measured on FDG PET in Patients With Richter Syndrome. (February 2020)
- Record Type:
- Journal Article
- Title:
- Prognostic Value of Baseline Total Metabolic Tumor Volume Measured on FDG PET in Patients With Richter Syndrome. (February 2020)
- Main Title:
- Prognostic Value of Baseline Total Metabolic Tumor Volume Measured on FDG PET in Patients With Richter Syndrome
- Authors:
- Pontoizeau, Clémence
Girard, Antoine
Mesbah, Habiba
Haumont, Laure-Anne
Devillers, Anne
Tempescul, Adrian
Salaün, Pierre-Yves
Lamy, Thierry
Le Jeune, Florence
Palard-Novello, Xavier - Abstract:
- Abstract : Purpose: We evaluated the prognostic value of baseline total metabolic tumor volume (TMTV) measured using pretreatment FDG PET for patients with transformation of chronic lymphocytic leukemia (CLL) into diffuse large B-cell lymphoma (DLBCL). Methods: A total of 28 patients with transformation of CLL into DLBCL who had undergone FDG PET before treatment were retrospectively reviewed. Univariate and multivariate analysis of conventional clinicopathologic variables (sex, age, World Health Organization performance status score, International Prognostic Index score, Binet stage, lactate dehydrogenase serum level [LDH], platelet count, presence or not of prior therapies for CLL, the time from CLL to Richter syndrome, Ann Arbor stage, Bulky or not) and metabolic parameters (SUVmax, SUVmean, TMTV, and total lesion glycolysis) at the time of the transformation of CLL into DLBCL were tested for overall survival (OS). Results: Of the 28 patients, 14 patients (50%) died during the follow-up period. Low platelet count, World Health Organization performance status score >1, high LDH, and high TMTV were found to be significant prognostic factors for OS on univariate analysis. The 5-year estimates of OS were 63% in the low metabolic burden group (TMTV ⩽1200 cm 3 ) and 0% in the high metabolic burden group (TMTV >1200 cm 3 ). Multivariate analysis revealed that only high LDH was a significant predictor after adjustment for other variables of OS. Conclusions: TMTV extracted fromAbstract : Purpose: We evaluated the prognostic value of baseline total metabolic tumor volume (TMTV) measured using pretreatment FDG PET for patients with transformation of chronic lymphocytic leukemia (CLL) into diffuse large B-cell lymphoma (DLBCL). Methods: A total of 28 patients with transformation of CLL into DLBCL who had undergone FDG PET before treatment were retrospectively reviewed. Univariate and multivariate analysis of conventional clinicopathologic variables (sex, age, World Health Organization performance status score, International Prognostic Index score, Binet stage, lactate dehydrogenase serum level [LDH], platelet count, presence or not of prior therapies for CLL, the time from CLL to Richter syndrome, Ann Arbor stage, Bulky or not) and metabolic parameters (SUVmax, SUVmean, TMTV, and total lesion glycolysis) at the time of the transformation of CLL into DLBCL were tested for overall survival (OS). Results: Of the 28 patients, 14 patients (50%) died during the follow-up period. Low platelet count, World Health Organization performance status score >1, high LDH, and high TMTV were found to be significant prognostic factors for OS on univariate analysis. The 5-year estimates of OS were 63% in the low metabolic burden group (TMTV ⩽1200 cm 3 ) and 0% in the high metabolic burden group (TMTV >1200 cm 3 ). Multivariate analysis revealed that only high LDH was a significant predictor after adjustment for other variables of OS. Conclusions: TMTV extracted from FDG PET at the time of the transformation of CLL into DLBCL is a predictor of OS. … (more)
- Is Part Of:
- Clinical nuclear medicine. Volume 45:Number 2(2020)
- Journal:
- Clinical nuclear medicine
- Issue:
- Volume 45:Number 2(2020)
- Issue Display:
- Volume 45, Issue 2 (2020)
- Year:
- 2020
- Volume:
- 45
- Issue:
- 2
- Issue Sort Value:
- 2020-0045-0002-0000
- Page Start:
- Page End:
- Publication Date:
- 2020-02
- Subjects:
- FDG PET -- Richter syndrome -- total metabolic tumor volume
Nuclear medicine -- Periodicals
Radioisotope scanning -- Periodicals
Nuclear Medicine -- Periodicals
616.07575 - Journal URLs:
- http://gateway.ovid.com/ovidweb.cgi?T=JS&MODE=ovid&NEWS=n&PAGE=toc&D=ovft&AN=00003072-000000000-00000 ↗
http://journals.lww.com/nuclearmed/pages/default.aspx ↗
http://journals.lww.com ↗ - DOI:
- 10.1097/RLU.0000000000002879 ↗
- Languages:
- English
- ISSNs:
- 0363-9762
- Deposit Type:
- Legaldeposit
- View Content:
- Available online (eLD content is only available in our Reading Rooms) ↗
- Physical Locations:
- British Library DSC - 3286.314000
British Library DSC - BLDSS-3PM
British Library STI - ELD Digital store - Ingest File:
- 17307.xml